Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 31, 2001 - Issue 8-9
Submit an article Journal homepage
346
Views
95
CrossRef citations to date
0
Altmetric
Research Article

Utility of metabolic stability screening: comparison of in vitro and in vivo clearance

S. E. Clarke Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Pharmaceuticals, The Frythe, Welwyn AL6 9AR, UK
&
P. Jeffrey Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Pharmaceuticals, The Frythe, Welwyn AL6 9AR, UK
Pages 591-598 | Published online: 22 Sep 2008

References

  • BENET, L. Z. and ZIA-ÄMIRHOSSEINI, P., 1995, Basic principles of pharmacokinetics. Toxicologic Pathology, 23, 115–123.
  • CARLILE, D. J., HAKOOZ, N., BAYLISS, M. K. and HOUSTON, J. B., 1999, Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans. British Journal of Clinical Pharmacology, 47, 625–635.
  • CLARKE, S. E., BALDWIN, S. J., BLOOMER, J. C., AYRTON, A. D., Sozio, R. S. and CHENERY, R. J., 1994, Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chemical Research in Toxicology, 7, 836–842.
  • CRESPI, C. L., MILLER, V. P. and PENMAN, B. W., 1997, Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Analytical Biochemistry, 248, 188–190.
  • HOUSTON, J. B. and CARLILE, D. J., 1997, Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. Drug Metabolism Reviews, 29, 891–922.
  • HOUSTON, J. B. and KENWORTHY, K. E., 2000, In vitro—in vivo scaling of CYP kinetic data not consistent with the classical Michaelis—Menten model. Drug Metabolism and Disposition, 28, 246–254.
  • LIPINSKI, C. A., LOMBARDO, F., DOMINY, B. W. and FEENEY, P. J., 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25.
  • OBACIT, R. S., 1999, Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metabolism and Disposition, 27, 1350–1359.
  • RODRIGUES, A. D., 1997, Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective. Pharmaceutical Research, 14, 1504–1510.
  • SCHNEIDER, G., COASSOLO, P. and LAVE, T., 1999, Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. Journal of Medicinal Chemistry, 42, 5072–5076.
  • WILKINSON, G. R. and SHAND, G. G., 1975, A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics, 18, 377–390.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.